Comparison of pharmacokinetic variability of fesoterodine vs. tolterodine extended release in cytochrome P450 2D6 extensive and poor metabolizers
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2011.03948.x/fullpdf
Reference21 articles.
1. Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence;Andersson;Curr Opin Urol,2009
2. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis;Chapple;Eur Urol,2008
3. The mechanism of action of tolterodine;Nilvebrant;Rev Contemp Pharmacother,2000
4. Comparison of peripherally active substance for treatment of detrusor overactivity: what is new; what is in the pipeline;Tubaro;EAU Update Series,2004
5. Fesoterodine, an advanced antimuscarinic for the treatment of overactive bladder: a safety update;Cole;Drugs Future,2004
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacogenomic Biomarkers;Biomarkers in Medicine;2022-08-30
2. On-demand use of fesoterodine: a new paradigm for extended release antimuscarinics;International Urogynecology Journal;2022-06-06
3. Comprehensive overview of the available pharmacotherapy for the treatment of non-neurogenic overactive bladder in children;Expert Opinion on Pharmacotherapy;2022-05-06
4. Overactive Bladder Prescribing Considerations: The Role of Polypharmacy, Anticholinergic Burden, and CYP2D6 Drug‒Drug Interactions;Clinical Drug Investigation;2021-03-12
5. OAB und Dranginkontinenz;Medikamente in der Urologie;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3